Create an account or log in to participate in this activity
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between Boston University Henry M. Goldman School of Dental Medicine and Boston University Chobanian & Avedisian School of Medicine CCE.
Boston University Henry M. Goldman School of Dental Medicine is an ADA CERP recognized provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at www.ADA.org/CCEPR.
Boston University Henry M. Goldman School of Dental Medicine designates this educational activity for 1 CE credit.
In order to receive credit, participants must view the content of the program and complete the post-test and evaluation. Participants who receive a grade of 70% or greater on the post-test will receive credit.
Continuing education credits issued for participation in the CE activity may not apply toward license renewal in all licensing jurisdictions. It is the responsibility of each participant to verify the CE requirements of his/her licensing or regulatory agency.
Participants should retain the Verification of Participation document for their records. Reprints may be obtained upon request sent via email.
Original Release Date: September 11, 2015
Date of Most Recent Review: June 15, 2023
Expiration Date: June 14, 2024
Target Audience: General dentists, dental specialists
This one-hour program outlines opioid prescribing principles for general dentists and dental specialists, illustrated by a case study. This training covers the safe and competent use of opioids for managing acute moderate to severe dental pain.
At the conclusions of this activity, participants will be better able to:
Ruben Figueroa, DMD, MS, Course Director
Clinical Associate Professor
Department of Oral & Maxillofacial Surgery
Boston University Henry M. Goldman School of Dental Medicine
rubenf@bu.edu
Daniel P. Alford, MD, MPH, FACP
Associate Professor of Medicine
Boston University Chobanian & Avedisian School of Medicine
Boston Medical Center
dan.alford@bmc.org
Faculty members have no relevant financial relationships to disclose.
Susan Hayashi, PHD, and Nancy Keene, JBS International; Karin Wittch, Jeanne Tuerk, and Vincent DiFabio, American Association of Oral and Maxillofacial Surgeons; Melinda Campopiano, Substance Abuse and Mental Health Services Administration; and Ilana Hardesty, Boston University Chobanian & Avedisian School of Medicine. Planning Committee members have no relevant financial relationships to disclose.
For more information, please contact Continuing Medical Education at cme@bu.edu.
It is the policy of the Boston University Henry M. Goldman School of Dental Medicine, Continuing Education, that commercialism is not permitted in our programs, or must be fully disclosed to all participants in advance and during the program.
To view other Boston University's Policies, please see www.bu.edu/dental/ce/policies/
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.
SCOPE of Pain
© 2024 Trustees of Boston University. Site by Root802.